Sort
3,198 grants matching “mrna vaccine”
The Genome Analysis Core
$2,530,888Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIC · FY2022 · AI
Pushing the envelope: Optimizing vaccine display of flexibly linked HIV Env trimer immunogens
$2,525,443Christopher Parks · International Aids Vaccine Initiative · P01 · FY2016 · AI
Malaria Vaccines: TBV Antigens as Conjugates with Alternate Carriers
$2,510,151Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Optimizing malaria transmission-blocking vaccines with improved platforms
$2,473,905Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
CCR Genomics Core
$2,473,796Elizabeth Conner · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
SPORE in Soft Tissue Sarcoma
$2,453,831Samuel Singer · Sloan-Kettering Inst Can Research · P50 · FY2025 · CA
Pushing the envelope: Optimizing vaccine display of flexibly linked HIV Env trimer immunogens
$2,445,841Christopher Parks · International Aids Vaccine Initiative · P01 · FY2017 · AI
The Genome Analysis Core
$2,424,710Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIC · FY2023 · AI
Discovery of Chemical Probes and Therapeutic Leads, Phase II
$2,399,995Joseph M Fox · University Of Delaware · P20 · FY2024 · GM
Discovery of Chemical Probes and Therapeutic Leads, Phase II
$2,399,995Joseph M Fox · University Of Delaware · P20 · FY2023 · GM
Respiratory pathogen-specific T cell signatures following vaccination, natural infection, and treatment
$2,391,540Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2022 · AI
Respiratory pathogen-specific T cell signatures following vaccination, natural infection, and treatment
$2,391,540Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2023 · AI
Respiratory pathogen-specific T cell signatures following vaccination, natural infection, and treatment
$2,391,540Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2024 · AI
Immune signatures of vaccine responses in vulnerable populations
$2,388,688Ruth R Montgomery · Yale University · U19 · FY2025 · AI
A Global Syphilis Vaccine Targeting Outer Membrane Proteins of Treponema pallidum
$2,387,026Michael Anthony Moody · Duke University · U01 · FY2024 · AI
SPORE in Soft Tissue Sarcoma
$2,375,406Samuel Singer · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
Discovery of Chemical Probes and Therapeutic Leads, Phase II
$2,359,432Joseph M Fox · University Of Delaware · P20 · FY2022 · GM
Discovery of Chemical Probes and Therapeutic Leads, Phase II
$2,359,432Joseph M Fox · University Of Delaware · P20 · FY2021 · GM
RNA-based HIV-1 chimera vaccines encoding a trimerizing host self-protein protomer linked to a viral MPER-TM segment
$2,356,969Ellis L Reinherz · Dana-Farber Cancer Inst · P01 · FY2024 · AI
Pushing the envelope: Optimizing vaccine display of flexibly linked HIV Env trimer immunogens
$2,353,868Christopher Parks · International Aids Vaccine Initiative · P01 · FY2019 · AI
Discovery of Chemical Probes and Therapeutic Leads, Phase II
$2,349,582Joseph M Fox · University Of Delaware · P20 · FY2020 · GM
IMMUNE MECHANISMS CONTROLLING INFLAMMATION AND CANCER
$2,344,199Dartmouth College · P20 · FY2003 · RR
IMMUNE MECHANISMS CONTROLLING INFLAMMATION AND CANCER
$2,343,963Dartmouth College · P20 · FY2004 · RR
HIV/AIDS Vaccine and Antibody Development
$2,325,099Cheng Cheng · National Institute Of Allergy And Infectious Diseases · ZIC · FY2023 · AI
Personalized Clinical Diagnostics and Beyond: Integrated Ring Resonator Arrays
$2,325,000Ryan C Bailey · University Of Illinois At Urbana-Champaign · DP2 · FY2007 · OD